Quality of Life Among Breast Reduction Patients
Study Details
Study Description
Brief Summary
Despite the growing evidence showing that breast hypertrophy is associated with reduced Health-Related Quality of Life (HRQL) and that reduction mammoplasty has a significant positive impact on HRQL, there are unresolved issues that need to be addressed. These include our ability to measure quantitatively the change that occurs after reduction and the ongoing restriction or denials of third party payments based on body mass index (BMI). The primary purpose of this study is to assess and measure the HRQL experienced by breast reduction patients using four reliable and validated HRQL measures.
Fifty-two consecutive patients with the diagnosis of breast hypertrophy were invited to participate in this prospective study. Participants completed the Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3) and the Breast Reduction Assessment Value and Outcomes (BRAVO) instruments (the Short Form 36, the Multidimensional Body-Self Rating Questionnaire Appearance Assessment, and the Breast Related Symptom Questionnaire) at one week and one day pre-surgery and one, six, and 12 months post-surgery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
This study addresses the following questions of clinical and policy relevance: 1) Is the pre-surgery HRQL of these patients compromised and, if so, in which areas? 2) Do patients' HRQL improve after surgery and, if so, when and in which areas and by how much? 3) Is there a relationship between BMI and pre-/post-surgery changes in HRQL (i.e., is the pre/post effect similar for both obese and non-obese patients)? and 4) Is there a relationship between tissue re-section weight and pre-/post-surgery changes in HRQL (i.e., is the pre/post HRQL effect similar for patients having small and large amounts of tissue resected)?
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diagnosis of breast hypertrophy
-
Government approval for payment of reduction mammoplasty
Exclusion Criteria:
- Unable or unwilling to complete the quality of life questionnaires
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | St. Joseph's Healthcare / McMaster University | Hamilton | Ontario | Canada | L8N 4A6 |
Sponsors and Collaborators
- Hamilton Health Sciences Corporation
Investigators
- Principal Investigator: Achilleas Thoma, MD MSc FRCSC, McMaster Univeristy / St. Joseph's Healthcare
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 02-09-2005